Vaginal Progesterone Effects on Ultrasound Indices, Fetal Outcomes, and Preeclampsia in High-risk Pregnancy
DOI:
https://doi.org/10.31661/gmj.v14i.3745Keywords:
Preeclampsia; Progesterone; Aspirin; Uterine ArteryAbstract
Background: According to the high prevalence and importance of preeclampsia and its relationship with uterine artery resistance, the purpose of this study was to determine the effect of vaginal progesterone administration on ultrasound indices, fetal outcomes, and high-risk women pregnancy in terms of the incidence of preeclampsia. Materials and Methods: In this randomized, double-blind clinical trial, the number of 60 pregnant women between 11 to 14 weeks with risk factors for preeclampsia were examined according to the inclusion criteria and based on random assignation method in two groups of 30 patients (intervention group: 80 mg aspirin tablets + 400 mg vaginal progesterone suppositories and control group: 80 mg aspirin tablets) based on maternal and fetal outcomes and uterine artery color Doppler ultrasound (pulsatility index (PI) and vascular resistance index (RI). Results: The prevalence of preterm birth in the intervention group was lower significantly difference (P≤0.05). In the intervention group, uterine artery PI after the study had a greater decrease than before the study on the right side (0.33±0.42 vs. 0.05±0.28, P≤0.05) and on the left side (0.38±0.49 vs. 0.09±0.2, P≤0.05), compared to the control group. In the intervention group, uterine artery RI after the study had a greater decrease than before the study on the right side (0.20±0.31 vs. 0.02±0.10, P≤0.05) and on the left side (0.22±0.3 vs. 0.03 ± 0.1, P≤0.05), compared to the control group. Conclusion: Progesterone suppositories in addition to aspirin, can reduce the prevalence of preterm birth and uterine artery PI and RI values.
References
Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364.
https://doi.org/10.1186/s12884-021-03809-2
PMid:33964896 PMCid:PMC8106862
Connealy BD, Carreno CA, Kase BA, Hart LA, Blackwell SC, Sibai BM. A history of prior preeclampsia as a risk factor for preterm birth. Am J Perinatol. 2014;31(6):483-8.
https://doi.org/10.1055/s-0033-1353439
PMid:23934539
Shah NM, Lai PF, Imami N, Johnson MR. Progesterone-related immune modulation of pregnancy and labor. Front Endocrinol (Lausanne). 2019;10:198.
https://doi.org/10.3389/fendo.2019.00198
PMid:30984115 PMCid:PMC6449726
Zhang H, Qi J, Wang Y, Sun J, Li Z, Sui L et al. Progesterone regulates glucose metabolism through glucose transporter 1 to promote endometrial receptivity. Front Physiol. 2020;11:543148.
https://doi.org/10.3389/fphys.2020.543148
PMid:33101047 PMCid:PMC7546771
Hausermann HM, Donnelly KM, Bell SC, Verhage HG, Fazleabas AT. Regulation of the glycosylated β-lactoglobulin homolog, glycodelin [placental protein 14:(PP14)] in the baboon (Papio anubis) uterus. J Clin Endocrinol Metab. 1998;83(4):1226-33.
https://doi.org/10.1210/jc.83.4.1226
PMid:9543146
Borna S, Borna H, Gotbizadeh F, Jahani M. Evaluation of progesterone effects on fetal Doppler velocimetry. J Obstet Gynecol Cancer Res. 2022;1(3):9399.
https://doi.org/10.17795/ojcr-9399
Vafaei H, Zamanpour T, Raeisi Shahraki H. Preterm birth prevention: effects of vaginal progesterone administration on blood flow impedance in uterine-fetal circulation by Doppler sonography. Glob J Health Sci. 2015;8(7):172-8.
https://doi.org/10.5539/gjhs.v8n7p172
PMid:26925899 PMCid:PMC4965675
Niromanesh S, Moghadam SF, Sherbaf FR. Maternal and fetal Doppler blood flow velocimetry changes in the management of asymptomatic preterm labor with vaginal progesterone tablet. Acta Med Iran. 2018;56(6):398-404.
Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J. 2005;46(5):826-31.
Qu H, Khalil RA. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. Am J Physiol Heart Circ Physiol. 2020;319(3):H661-H81.
https://doi.org/10.1152/ajpheart.00202.2020
PMid:32762557 PMCid:PMC7509272
Malhotra A, Allison BJ, Castillo-Melendez M, Jenkin G, Polglase GR, Miller SL. Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front Endocrinol (Lausanne). 2019;10:55.
https://doi.org/10.3389/fendo.2019.00055
PMid:30792696 PMCid:PMC6374308
Simons NE, van Limburg Stirum EVJ, van Wassenaer-Leemhuis AG, Finken MJJ, Aarnoudse-Moens CSH, Oosterlaan J. Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up. BMJ Open. 2021;11(9):e053066.
https://doi.org/10.1136/bmjopen-2021-053066
PMid:34548367 PMCid:PMC8458362
Siemienowicz KJ, Wang Y, Marečková M, Nio-Kobayashi J, Fowler PA, Rae MT et al. Early pregnancy maternal progesterone administration alters pituitary and testis function and steroid profile in male fetuses. Sci Rep. 2020;10(1):21920.
https://doi.org/10.1038/s41598-020-78976-x
PMid:33318609 PMCid:PMC7736841
Melo P, Devall A, Shennan AH, Vatish M, Becker CM, Granne I. Vaginal micronised progesterone for the prevention of hypertensive disorders of pregnancy: a systematic review and meta-analysis. BJOG. 2024;131(6):727-39.
https://doi.org/10.1111/1471-0528.17705
PMid:37941309
Savaj S, Vaziri N. An overview of recent advances in pathogenesis and diagnosis of preeclampsia. Iran J Kidney Dis. 2012;6(5):334-8.
Maged AM, Shoab AY, Hussein EA, Alsawaf AH, Mahmoud DS, AbdAllah AA. The effect of antenatal vaginal progesterone administration on uterine, umbilical, and fetal middle cerebral artery Doppler flow: a cohort study. Am J Perinatol. 2020;37(5):491-6.
https://doi.org/10.1055/s-0039-1683438
PMid:30866028
Xu H, Zhang XQ, Zhu XL, Weng HN, Xu LQ, Huang L et al. Comparison of vaginal progesterone gel combined with oral dydrogesterone versus intramuscular progesterone for luteal support in hormone replacement therapy-frozen embryo transfer cycle. J Gynecol Obstet Hum Reprod. 2021;50(7):102110.
https://doi.org/10.1016/j.jogoh.2021.102110
PMid:33727207
Pakniat H, Ansari I, Kashanipour N, Movahed F. Effect of vaginal progesterone and dydrogesterone on pregnancy outcomes in patients with threatened abortion: a randomized clinical trial. Iran J Obstet Gynecol Infertil. 2021;24(1):18-25.
Movahed F, Pakniat H, Abbasi S. Effects of vaginal progesterone suppository on uterine artery resistance in women with threatened abortion. Koomesh. 2019;21(3):444-8.
Xie J, Li N, Bai H, Shi J, Cai H. Overweight and obesity affect the efficacy of vaginal vs intramuscular progesterone for luteal-phase support in vitrified-warmed blastocyst transfer. Fertil Steril. 2023;119(4):606-15.
https://doi.org/10.1016/j.fertnstert.2022.12.034
PMid:36567035
Çintesun E, İncesu Çintesun FN, Mammadova N, Çelik Ç. The influence of vaginal progesterone on uterine artery pulsatility index. Ginekol Pol. 2021;92(6):436-9.
https://doi.org/10.5603/GP.a2020.0178
PMid:33757153
Atzmon Y, Aslih N, Estrada D, Bilgory A, Ellenbogen A, Shalom-Paz E. Comparable Outcomes Using Oral Dydrogesterone Vs Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study. Reproductive Sciences. 2021;28(7):1874-81.
https://doi.org/10.1007/s43032-020-00376-3
PMid:33140324
Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742-9.
https://doi.org/10.1002/uog.5157
PMid:17899573
Gómez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32(2):128-32.
https://doi.org/10.1002/uog.5315
PMid:18457355
Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18-31.
https://doi.org/10.1002/uog.9017
PMid:21472815 PMCid:PMC3482512
Romero R, Conde-Agudelo A, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018;218(2):161-80.
https://doi.org/10.1016/j.ajog.2017.11.576
PMid:29157866 PMCid:PMC5987201
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216(2):110-20.e6.
https://doi.org/10.1016/j.ajog.2016.09.076
PMid:27640943
Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E et al. Vaginal progesterone vs cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol. 2013;208(1):42.
https://doi.org/10.1016/j.ajog.2012.10.877
PMid:23157855 PMCid:PMC3529767

Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.